Bioprocessing
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-06Oct 9, 2026
Pathfinder
Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?
Nice Insight
PAO-26-PF-28Oct 9, 2026
Formulation Models
Predictive Formulation: Can Modeling Reduce Empirical Development?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-04Oct 7, 2026
Pathfinder
Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?
Nice Insight
PAO-26-PF-27Oct 2, 2026
Viral CDMO
Choosing a CDMO That Can Grow with a Viral Program
Kai Lipinski, Ph.D.
Recipharm Advanced Bio
PAO-09-26-CL-08Oct 1, 2026
Viral Vectors
Gene Therapy Manufacturing After the Capacity Boom
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-01Oct 1, 2026
Spray Drying
Serán Bioscience Strengthens Spray Dry Capabilities with Growth Investment From Biospring Partners
Serán Bioscience
PR-09-26-05Sep 29, 2026
Biocatalysis
When Does Biocatalysis Create the Better Manufacturing Process?
Yusho Kato
Kaneka
PAO-09-26-CL-07Sep 28, 2026
DS + DP Integration
Integrating Drug Substance and Drug Product to Reduce Risk Across Development
Dörthe Ackenhausen
IDT Biologika
PAO-09-26-CL-02Sep 24, 2026
Multi-Modality CDMO
The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity
Kamal Preet
OneSource Specialty Pharma
PAO-09-26-CL-06Sep 24, 2026
AMT Designation
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
AustinPx
PR-09-26-04Sep 23, 2026
Oncolytic Viruses
Turning Oncolytic Viruses into Manufacturable Cancer Therapies
Luisa Amoedo Otero
Recipharm Advanced Bio
PAO-09-26-CL-04Sep 22, 2026
DDC Development
Building Better Combination Products by Engaging Device Development Earlier
Loganathan S.
OneSource Specialty Pharma
PAO-09-26-CL-05Sep 22, 2026
Drug Shortage
What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-16Sep 22, 2026
DSP
Why More Product Upstream Creates New Pressure Downstream
Pharma's Almanac
PAO-09-26-PA-15Sep 21, 2026
Enzymatic Synthesis
Transforming Enzymatic Processes into Commercial-Scale Manufacturing
Kohei Mori
Kaneka
PAO-09-26-CL-03Sep 18, 2026
Pathfinder
Platform Development vs. Molecule-Specific Process Development: Which Strategy Is Better for Biologics?
Nice Insight
PAO-26-PF-25Sep 18, 2026
Oncolytic Viruses
Manufacturing Oncolytic Viruses: Where Complexity Demands Experience
Mathias Kahl
IDT Biologika
PAO-09-26-CL-01Sep 17, 2026
M&A
Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies
Kincellis Advanced Therapies
PR-09-26-03Sep 17, 2026
Biosimilars
The Global Division of Labor Behind the Coming Oncology Biosimilar Wave
Pharma's Almanac
PAO-09-26-PA-18Sep 15, 2026